Overt immediate hemolytic transfusion reaction attributable to anti-Wra
Mar 24, 2020
About this article
Article Category: Case Report
Published Online: Mar 24, 2020
Page range: 113 - 115
DOI: https://doi.org/10.21307/immunohematology-2019-282
Keywords
© 2008 F.N. Boctor, published by Sciendo
Wra is a low-prevalence antigen. Anti-Wra is a relatively common antibody present in approximately 1 in 100 healthy blood donors. Anti-Wra is reported to cause different degrees of hemolysis in transfusion and in HDN, ranging from benign to severe. This report describes an acute overt hemolytic transfusion reaction in a patient whose serum contained anti-Wra and who received a Wr(a+) RBC component.